Nagaokakyo, Japan

Nobuhara Kakeya

This inventor holds 1 USPTO granted patent. Top assignee: Kyoto Pharmaceutical Industries, Ltd.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nobuhara Kakeya. Retrieved from https://idiyas.com/inventor/nobuhara-kakeya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nobuhara Kakeya: Innovator in Pharmaceutical Chemistry

Introduction

Nobuhara Kakeya is a notable inventor based in Nagaokakyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on drug compounds. His expertise and dedication have led to advancements that benefit the medical community.

Latest Patents

Kakeya holds a patent for "Cromoglycic acid derivatives, method of production thereof." This patent showcases his ability to develop new chemical compounds that can have therapeutic applications. He has a total of 1 patent to his name, reflecting his focused contributions to the field.

Career Highlights

Kakeya is associated with Kyoto Pharmaceutical Industries, Ltd., where he applies his knowledge and skills to advance pharmaceutical research and development. His work at this esteemed company has positioned him as a key player in the industry.

Collaborations

Throughout his career, Kakeya has collaborated with talented individuals such as Hirokazu Tsuda and Satoshi Tamaki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Nobuhara Kakeya's contributions to pharmaceutical chemistry through his patent and work at Kyoto Pharmaceutical Industries, Ltd. highlight his role as an important inventor in the field. His dedication to innovation continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…